Stock Earnings

Question 1

What are Molecular Partners AG's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Molecular Partners AG has a total asset of $102, Net loss of $-61

Question 2

What are the key financial ratios for MLLCF?

Accepted Answer

Molecular Partners AG's Current ratio is 4.85, has a Net margin is 0, sales per share of $0.

Question 3

How is Molecular Partners AG's revenue broken down by segment or geography?

Accepted Answer

Molecular Partners AG largest revenue segment is Biopharmaceutical Products, at a revenue of 7,038,000 in the most earnings release.For geography, Switzerland is the primary market for Molecular Partners AG, at a revenue of 7,038,000.

Question 4

Is Molecular Partners AG profitable?

Accepted Answer

no, according to the latest financial statements, Molecular Partners AG has a net loss of $-61

Question 5

Does Molecular Partners AG have any liabilities?

Accepted Answer

yes, Molecular Partners AG has liability of 21

Question 6

How many outstanding shares for Molecular Partners AG?

Accepted Answer

Molecular Partners AG has a total outstanding shares of 37.41

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	0	0	4	7	189	9
Revenue Growth (YoY)	-100%	-100%	-43%	-96%	2,000%	0%
Cost of Revenue	--	0	0	0	1	0
Gross Profit	--	0	4	7	188	9
Selling, General & Admin	15	14	17	18	21	16
Research & Development	40	38	46	46	47	53
Operating Expenses	55	55	66	68	71	73
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-61	-61	-54	-61	117	-63
Income Tax Expense	0	0	0	0	0	0
Net Income	-61	-61	-54	-61	117	-63
Net Income Growth	13%	13%	-11%	-152%	-286%	2%
Shares Outstanding (Diluted)	37.71	37.27	34.03	32.77	32.47	31
Shares Change (YoY)	2%	10%	4%	1%	5%	24%
EPS (Diluted)	-1.63	-1.65	-1.58	-1.89	3.62	-2.05
EPS Growth	12%	4%	-16%	-152%	-276%	-18%
Free Cash Flow	-51	-51	-59	-59	117	-92
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	0%	100%	100%	99.47%	100%
Operating Margin	0%	0%	-1,525%	-871.42%	61.37%	-700%
Profit Margin	0%	0%	-1,350%	-871.42%	61.9%	-700%
Free Cash Flow Margin	0%	0%	-1,475%	-842.85%	61.9%	-1,022.22%
EBITDA	-53	-53	-59	-59	118	-61
EBITDA Margin	0%	0%	-1,475%	-842.85%	62.43%	-677.77%
D&A For EBITDA	2	2	2	2	2	2
EBIT	-55	-55	-61	-61	116	-63
EBIT Margin	0%	0%	-1,525%	-871.42%	61.37%	-700%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Molecular Partners AG (MLLCF) Financial

MLLCF Stock Price Chart

MLLCF Income

Follow-Up Questions

What are Molecular Partners AG's key financial statements?

What are the key financial ratios for MLLCF?

How is Molecular Partners AG's revenue broken down by segment or geography?

Is Molecular Partners AG profitable?

Does Molecular Partners AG have any liabilities?

How many outstanding shares for Molecular Partners AG?

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is Molecular Partners AG?